NCT03004365View on ClinicalTrials.gov

A Study to Evaluate the Safety and Microbiology of C16G2 Varnish Administered in Multiple Doses to Dental Subjects

PHASE2CompletedINTERVENTIONAL
Enrollment

33

Participants

Timeline

Start Date

January 27, 2017

Primary Completion Date

March 29, 2017

Study Completion Date

March 29, 2017

Conditions
Dental Caries
Interventions
DRUG

C16G2 Varnish

Antimicrobial Peptide

DRUG

Placebo Varnish

Placebo

Trial Locations (3)

59901

John F. Pittaway, DMD, Kalispell

75063

Anthony Henegar, DDS, PA, Irving

76021

Jacqueline Kleven, DDS, Bedford

Sponsors
All Listed Sponsors
lead

Armata Pharmaceuticals, Inc.

INDUSTRY